Qube Research & Technologies LTD Alkermes Plc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Alkermes Plc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 245,334 shares of ALKS stock, worth $6.96 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
245,334
Previous 74,880
227.64%
Holding current value
$6.96 Million
Previous $2.03 Million
191.66%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$825 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$567 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$407 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$312 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$261 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.66B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...